Anna L Blois

Title: Anna L. Blois: Innovator in Cancer Treatment

Introduction

Anna L. Blois is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on addressing cancer and fibrotic disorders, showcasing her dedication to improving patient outcomes.

Latest Patents

Anna L. Blois holds a patent for "Methods for the treatment of a cancer or fibrotic disorder associated with MENA or MENA(INV) by administering a map kinase inhibitor." This patent outlines how the phosphorylation and dephosphorylation of MENA and its isoforms regulate the metastatic activity of cancer cells. The administration of a MENA kinase inhibitor leads to a significant reduction in the development of cancer metastasis in both established and developing tumors. Furthermore, combining a MENA kinase inhibitor with a tyrosine kinase inhibitor enhances the efficacy of tyrosine kinase inhibitor therapy. Additionally, this combination results in a significant reduction in chemotherapy-induced tumor cell dissemination and improves the effectiveness of anti-microtubule therapy.

Career Highlights

Anna L. Blois has established herself as a key figure in cancer research. Her innovative approaches and dedication to her work have led to advancements in treatment methodologies. She is currently associated with Metastat, Inc., where she continues to develop her groundbreaking ideas.

Collaborations

Anna collaborates with Douglas Hamilton, further enhancing her research efforts and contributing to the advancement of cancer treatment methodologies.

Conclusion

Anna L. Blois is a remarkable inventor whose work in cancer treatment is paving the way for new therapeutic strategies. Her patented methods demonstrate her commitment to addressing critical health challenges and improving the lives of patients.